RxDoctor Payments Data

Brian Borg, MD

Gastroenterology · Jackson, MSNPI 1902916778

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Madrigal Pharmaceuticals at 31.0% of the total. Reporting peaked in 2024 at $29,295 and has fallen 63.8% since, to $10,608 in 2025. Among gastroenterology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$67,706in general payments, 2019–2025

Across 363 payments — averaging $186.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Madrigal Pharmaceuticals$21K
  • Gilead$18K
  • Intercept Pharmaceuticals, Inc.$15K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$4K
  • Sanofi$2K
  • Bristol Myers Squibb$1K
  • plus $6K from 25 others
$1,659,885in research payments, 2019–2025

Across 324 payments — averaging $5123.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$601K
  • Gilead$272K
  • AbbVie$214K
  • Eli Lilly$170K
  • Bristol Myers Squibb$145K
  • Novartis$57K
  • plus $200K from 13 others

What the payments were for

  • Consulting fees$18,74528%
  • Speaking & faculty fees$29,86644%
  • Travel & lodging$5,7468%
  • Food & beverage$13,26020%
  • Education$900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$67,706 in reported general payments places this provider in the 95th percentile of 127 gastroenterology providers in Mississippi.

See all gastroenterology providers in Mississippi

Medicare billing

Part B allowed, 2024
$38,342
Medicare patients
178
Services billed
339

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ursodiol17$1,272
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl15$251

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →